GenomeKey utilizes advanced genomic sequencing technology to analyze genetic data for personalized medicine applications. The company provides insights that enhance treatment efficacy and reduce adverse drug reactions, improving patient outcomes in healthcare.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Ineffective medication selection and dosing leads to adverse drug reactions and suboptimal treatment outcomes. Traditional approaches to prescribing often overlook individual genetic variations that significantly impact drug metabolism and response. This trial-and-error method can prolong patient suffering and increase healthcare costs.
Solution
GenomeKey offers a comprehensive pharmacogenomics (PGx) testing service that analyzes an individual's genetic profile to predict their response to specific medications. By identifying genetic variants affecting drug metabolism, transport, and target interaction, GenomeKey provides clinicians with actionable insights to optimize drug selection and dosage. This personalized approach minimizes the risk of adverse reactions, enhances treatment efficacy, and improves overall patient outcomes. The service integrates seamlessly into existing clinical workflows, providing easy-to-interpret reports that guide prescribing decisions.
Target Audience
GenomeKey's primary customers are physicians, pharmacists, and healthcare providers seeking to improve medication management and personalize treatment plans for their patients.
Features
- Comprehensive PGx panel covering a wide range of commonly prescribed medications
- Advanced sequencing technology for accurate and reliable genotyping
- Proprietary algorithms that translate genetic data into personalized drug recommendations
- Clinician-friendly reports with clear, concise interpretations and actionable guidance
- Integration with electronic health record (EHR) systems for seamless data access
- Continuous updates to incorporate the latest scientific evidence and drug-gene interactions
- Secure data storage and HIPAA-compliant privacy practices